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ABSTRACT 
Thiadiazole is a heterocyclic compound containg both two nitrogen atom and one sulfur atom as a 
part of the aromatic five-membered ring. The imidazo [2,1-b]-1,3,4-thiadiazole ring system is the 
core skeleton of well known immunomodulator levamisole. The synthesis and antimicrobial 
activity of nine 6-Phenyl-2- substituted imidazo [2,1-b]-1,3,4-thiadiazole derivatives were reported 
against Gram +ve bacteria  Bacillius  subtilis (MTCC 121),  Staphyloccus aureus (MTCC 87),  
Gram –ve bacteria  Pseudomonas aeruginosa (MTCC 424),  Escherichia coli (MTCC 40),  and 
fungal strains  Candida albicans (MTCC 183),  Fusarium solani (MTCC 2935),   Fusarium 
oxyporium (MTCC 2840). Ciprofloxacin and Fluconazole were used as standard drug for 
antibacterial and antifungal activity respectively. The synthesized compound (6) and (5b) had 
moderate antibacterial activity especially with Gram negative Escherichia coli (MTCC 40) where 
(5a) and (5f) had good antibacterial activity. The structures of the synthesized compounds were 
established by IR, NMR and Mass spectral studies. 
Introduction 
 
An anti-microbial is a substance that kills or inhibits the growth 
of microoraganisms such as bacteria, fungi, or protozoans [1]. 
The discovery of antimicrobials like penicillin and tetracycline 
paved the way for better health for millions around the world. 
Now, most of these infections can be cured easily with a short 
course of antimicrobials. However, with the development of 
antimicrobials, microorganisms have adapted and become 
resistant to previous antimicrobial agents. The old antimicrobial 
technology was based either on poisons or heavy metals, which 
may not have killed the microbe completely, allowing the 
microbe to survive, change, and become resistant to the poisons 
and or heavy metals. 
Microorganisms exhibit the greatest genetic and metabolic 
diversities. They are an essential component of the biosphere 
and serve an important role in the maintenance and 
sustainability of ecosystem [2]. Antimicrobials differ in their 
physical, chemical and pharmacological properties. They also 
differ in their antibacterial spectrum of activity and mechanism 
of action. The major mechanism of action include inhibition of 
cell wall synthesis e.g. penicillin, inhibition of ribosome 
function e.g. erythromycin, inhibition of nucleic acid synthesis 
e.g. hydroxyurea, inhibition of folate metabolism e.g. 
methotrexate and inhibition of membrane function e.g. 
polymixin [3]. 
Compounds containing imidazo [2,1-b][1,3,4] thiadiazole 
heterocyclic system are known to posses interesting 
pharmacological properties such as Anticancer [4],  
Antitubercular [5], Antibacterial [6], Antifungal [7], 
Anticonvulsant, Analgesic [8],  Antisecretory [9], Anti-
inflammatory [10], Cardiotonic [11]. 
The imidazo [2,1-b]-1,3,4-thiadiazole ring system is the core 
skeleton of well known immunomodulator levamisole [12]. The 
use of antimicrobial agents is critical to successful treatment of 
infectious diseases. Although there are numerous classes of 
drugs that are routinely used to treat infections in humans, there 
are several reasons why the discovery and development of new 
antimicrobial agents are important. Over the past decade there 
has been an increased development of resistance in organisms 
that are typical pathogens in humans. These include 
methicillin/oxacillin-resistant Staphylococcus aureus, 
vancomycin resistant and intermediate Staphylococcus aureus, 
vancomycin-resistant Enterococcus, gram-negative bacilli that 
produce extended spectrum betalactamases, carbapenem-
resistant Klebsiella pneumoniae, and Pseudomonas and 
Acinetobacter strains that are resistant to all antibiotics that are 
typically used for treatment. This increased resistance has 
limited the selection of antimicrobials that may be used to treat 
specific organisms. New antimicrobials are also needed for 
certain groups of organisms. Very limited numbers of 
antimicrobials are available to treat infections caused by fungi 
and mycobacteria. Infections with these organisms continue to 
be a major concern. 
Although many infectious diseases have been known for 
thousands of years, over the past 30 years a number of new 
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infectious diseases have been discovered. Some examples 
include Lyme disease caused by Borrelia burgdorferi, 
Legionnaires’ disease caused by Legionella pneumophila, 
peptic ulcers caused by Helicobacter pylori, antibiotic 
associated diarrhea caused by Clostridium difficile and AIDS 
caused by Human Immunodeficiency Virus [12]. 
Chemotherapy for cancer treatment, immunosuppressive drugs 
for treatment of autoimmune diseases and organ transplant 
recipients and infections (such as AIDS) that alter the 
effectiveness of the host immune system render individuals at 
high risk for fungal infections and certain mycobacterial 
infections [13]. Often these infections are caused by 
environmental organisms that would not typically cause disease 
in a normal host[14]. 
Experimental 
 
The commercial chemicals employed for the present work were 
purchased from Sigma-Aldrich, Merck India and Loba Chem. 
All the solvents were used after distillation. Thin layer 
chromatography was performed on E Merck silica gel 60F254 
precoated plates and the identification was done with UV light 
and iodine chambers. Various solvent systems used for 
developing chromatograms were chloroform: methanol (9:1), 
chloroform: methanol (9.5:0.5), benzene: acetone (9:1). 
Melting points were determined in open capillaries on a Buchi-
apparatus and are uncorrected. The identification and 
characterization of the compounds were carried out by 
determining melting point, IR, 1H NMR, 13C NMR and Mass 
spectroscopy. All the infra red (IR) spectra (KBr) were 
recorded on the FT-IR Perkin-Elmer spectrometer (4000-400 
cm-1). 1H NMR and 13C NMR spectra were recorded on Bruker 
Avance II 400 spectrometer where TMS was used as internal 
standard and chemical shifts are expressed as δ ppm. The Mass 
spectra were run on micromas Q-T of micro spectrometer at 
SAIF Panjab University, Chandigarh. 
Synthesis of 5-p-substituted-1,3,4–thiadiazol-2-amine 3(a-b) 
Substituted benzoic acid (1a-b, 6.8 g, 0.05 mol) and 
thiosemicarbazide (4.5 g, 0.05 mol) in  phosphorous 
oxychloride (30 ml) were refluxed gently for 1-2 h. The 
solution was allowed to cooled and then water (90 ml) was 
added carefully (Scheme.1). The separated solid was filtered 
and suspended in water and basified with aqueous potassium 
hydroxide. The solid was filtered, washed with water, 
recrystallized with ethanol. 
5-Methyl-1,3,4–thiadiazol-2-amine (3a): This compound was 
obtained as crystalline solid/ light pink. Yield: 71%; Melting point: 
220-223°C; Rf 0.56 (Benzene: Acetone 7:3). 
5-Fluoro-1,3,4–thiadiazol-2-amine (3b):  This compound was 
obtained as crystalline solid/light yellow. Yield: 65%; Melting point: 
202-205°C; Rf 0.42 (Benzene: Acetone 7:3). 
Synthesis of 6-phenyl-2-p-substituted imidazo[2,1-
b][1,3,4]thiadiazole 5(a-f) 
A mixture of equimolar quantities of 5-p-substituted thiadiazole 
amine (3a-b, 1.91 g, 0.01 mol) and substituted phenacyl bromide 
(1.99 g, 0.01 mol) was refluxed in dry ethanol for 18-24 h 
(Scheme.1). The excess solvent was evaporated through vaccum 
filtration. The obtained solid product was suspended in water and 
the solution was neutralized by sodium carbonate solution to get 
water free base. The crude product was was filtered, washed with 
water, dried and recrystallized with ethanol. 
6-Phenyl-2-p-tolylimidazo[2,1-b][1,3,4]thiadiazole 5(a): State: 
crystalline solid/ light brown;  Yield: 41.43%; Melting Point: 
170-173ᵒC; Rf  0.62 (Benzene: Acetone 9:1); 1H NMR (400MHz, 
CDCl3, ppm): 8.01 (s, 1H, CH ), 7.5- 7.8 (m, 9H, Ar-H ), 2.15 (s, 
3H, CH3) 
6-(4-Methoxyphenyl)-2-p-tolylimidazo[2,1-b][1,3,4] 
thiadiazole 5(b): This compound was obtained as crystalline 
solid/ light brown. Yield: 45.02%; Melting point: 179-182°C; Rf  
0.42 (Chloroform: Methanol 9:1); IR (KBr, ν, cm-1): 3134 (Ar-C-
H), 2936 (C-H); 1H NMR (400MHz, CDCl3, ppm): 3.8 (s, 3H, 
OCH3), 7.9 (s, 1H, CH), 6.9-7.7 (m, 8-H, Ar-H) 
 6-(4-Nitrophenyl)-2-p-tolylimidazo[2,1-b][1,3,4] thiadiazole 
5(c): This compound was obtained as crystalline solid/ light 
orange. Yield: 48.43%; Melting point: 224-247°C; Rf 0.48 
(Benzene: Acetone 9:1); IR (KBr, ν, cm-1): 1518, 1340 (N=O), 
3153 (Ar-C-H stretch), 2924 (C-H); 1H NMR (400MHz, CDCl3, 
ppm): 8.9 (s, 1H, CH), 2.5 (s, 3H, CH3), 7.4-8.2 (m, 9H, Ar-H) 
2-(4-fluoropheny)-6-(4-methoxyphenyl)imidazo[2,1-
b][1,3,4]thiadiazole 5(d): This compound was obtained as brown 
solid/ pale brown. Yield: 42.05%; Melting point: 217-220°C; Rf 
0.58 (Benzene: Acetone 7:1); IR (KBr, ν, cm-1): 1250 (C-F), 3089 
(Ar-C-H stretch); 1H NMR (400MHz, DMSO-d6, ppm): 3.8 (s, 
3H, OCH3), 8.3 (s, 1H, CH), 6.9-8.0 (m, 8H, Ar-H) 
2-(4-fluorophenyl)-6-p-tolylimidazo[2,1-b][1,3,4] thiadiazole 
5(e): This compound was obtained as crystalline solid/ light 
yellow. Yield: 38%; Melting point: 231-235°C; Rf 0.36 
(Chloroform: Methanol 9:1); IR (KBr, ν, cm-1): 1226 (C-F), 3100 
(Ar-C-H stretch), 2921(C-H);  1H NMR (400MHz, DMSO-d6, 
ppm): 8.1(s, 1H, CH), 7.2-7.9 (m, 8H, Ar-H), 2.3 (s, 1H, CH3) 
2,6-bis(4-fluorophenyl)imidazo[2,1-b][1,3,4]thiadiazole 5(f): 
This compound was obtained as crystalline solid/ light brown. 
Yield: 42%; Melting point: 239-242°C; Rf 0.55 (Benzene: 
Acetone 9:1); IR (KBr, ν, cm-1): 1240 (C-F), 3098 (Ar-C-H 
stretch); 1H NMR (400MHz, DMSO-d6, ppm): 8.3 (s, 1H, CH), 
7.1-7.9 (m, 9H, Ar-H) 
6-Phenyl-2-p-tolylimidazo[2,1-b][1,3,4]thiadiazole-5-
carbaldehyde (6) 
Vilsmeir- Haack reagent was prepared by adding phosphoryl-
chloride (3 ml) in dimethyl formamide (20 ml) at 0°C with 
stirring. Then 6-phenyl-2-p-tolylimidazo[2,1-b][1,3,4]thiadiazoles 
(1.91 g 0.01 mol) was added to the reagent and stirred for 2 h at 
room temperature and at 60°C for additional 2 h (Scheme.1). The 
mixture was then poured in sodium carbonate solution and stirred 
at 90°C for 2 h. After cooling, the mixture was diluted with water 
and extracted with chloroform. The residue obtained was 
recyrstallized from ethanol solvent to get crystalline solid. 
6-phenyl-2-p-tolylimidazo[2,1-b][1,3,4]thiadiazole-5-
carbaldehyde (6): This compound was obtained as crystalline 
solid/ light brown. Yield: 35%; Melting point: 174-178°C; Rf 0.45 
(Benzene: Acetone 9:1); IR (KBr, ν, cm-1): 1602 (C=O), 3116 
(Ar-C-H), 2918 (C-H); 1H NMR (400MHz, DMSO-d6, ppm): 
10.62 (s, 1H, CHO), 6.7-8.04 (m, 9-H, Ar-H), 2.3 (s, 3H, CH3) 
5-Nitroso-6-phenyl-2-p-tolylimidazo[2,1-b][1,3,4] 
thiadiazole (7) 
To a well stirred solution of (1.9 g, 0.01mol) 6-phenyl-2-p-
tolylimidazo[2,1-b][1,3,4]thiadiazoles (0.01 mol) in acetic acid 
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(10 ml ) was added sodium nitrite solution (1.49 ml, in 5 ml 
water) dropwise at room  temperature. After the addition, 
stirring was continued for 30 min and the mixture was refluxed 
for 2 h (Scheme.1). The reaction mixture was poured in to ice 
cold water, separated crude solid was collected, washed with 
water, dried and recrystallized from ethanol. 
5-Nitroso-6-phenyl-2-p-tolylimidazo[2,1-b][1,3,4] 
thiadiazole (7): This compound was obtained as crystalline 
solid/ light brown. Yield: 40%; Melting point: 142-145°C; Rf 
0.42 (Benzene: Acetone 9:1); IR (KBr, ν, cm-1): 1511, 1344 
(N=O), 3116 (Ar-C-H), 2918 (C-H); 1H NMR (400MHz, 
CDCl3, ppm): 7.1-7.9 (m, 9H, Ar-H), 2.3 (s, 1H, CH3) 
5-Bromo-6-phenyl-2-p-tolylimidazo[2,1-b][1,3,4] thiadiazole 
(8) 
To a well stirred solution of 6-phenyl-2-p-tolylimidazo[2,1-
b][1,3,4]thiadiazoles (0.01 mol) in glacial acetic acid (5 ml) and 
anhydrous sodium acetate (0.02 mol) was added bromine (0.1 
ml) dropwise with stirring at room  temperature (Scheme.1). 
After the addition, stirring was continued for 2 h. The reaction 
mixture was poured on to ice cold water and basified with 
ammonia solution. The separated solid was collected, washed 
with water and recrystallized with ethanol. 
5-Bromo-6-phenyl-2-p-tolylimidazo[2,1-b][1,3,4] thiadiazole 
(8): This compound was obtained as crystalline solid/ light 
brown. Yield: 45%; Melting point: 162-165°C; Rf 0.54 
(Benzene: Acetone 9:1); IR (KBr, ν, cm-1): 686 (C-Br), 3116 
(Ar-C-H), 2917 (C-H); 1HNMR (400MHz, CDCl3, ppm): 7.2-
8.0 (m, 9H, Ar-H), 2.15 (s, 3H, CH3) 
Antimicrobial screening by Agar well diffusion method 
Antimicrobial activity of new synthesized compounds 5(a-f), 
and 6-8 was carried out by the  Cup- Plate Agar Diffusion 
method against Gram +ve bacteria strains like Staphylolococcus 
aureus (MTCC 87), Bacillus subtilis (MTCC 121), and Gram –
ve bacterial strains like Pseudomonas aeruginosa (MTCC 424), 
Escherichia coli (MTCC 40) and fungal strains like Candida 
albicans (MTCC 183),  Fusarium solani (MTCC 2935),   
Fusarium oxyporium (MTCC 2840). All microorganisms were 
obtained from Institution of Microbial Technology (IMTECH) 
Chandigarh. The standards Ciprofloxacin and Fluconazole were 
dissolved in DMSO to get a  concentration 100μg/ml for testing 
antibacterial activity. Each test compounds was dissolved in 
DMSO to get a concentration of 100μg/ml for testing 
antibacterial activity. The zone of inhibition were observed and 
measured in mm. 
Results and Discussion 
As per the proposed protocol the synthesis of varied substituted 
imidazo[2,1-b][1,3,4]thiadiazoles is carried out. The 5-substituted 
1,3,4-thiadiazoles were synthesized in good yields by reacting 
thiosemicarbazide with substituted benzoic acid in presence of 
phosphorous oxy-chloride. The reaction proceeds via the 
intermediate iminothiadiazole which under reflux temperature 
spontaneously undergoes dehydrocyclisation to form the desired 
fused heterocycle. The electronic and steric factors at 5th position 
of 2-amino-5-substituted-1,3,4-thiadiazole are crucial in 
determining the course of its reaction with substituted α-
haloarylketones. The strongly electronegative groups imparts less 
nucleophillic character to the nitrogen at 4th position of the 1,3,4-
thiadiazole. Thus the different imidazo [2,1-b][1,3,4]thiadiazole 
derivatives were undergo electrophillic substitution reaction. All 
reactions were monitored through TLC observation till the 
completion using suitable mobile phase each time. After 
completion the reaction, the products were purified by using 
suitable solvents e.g. ethanol. The structures of all synthesized 
derivatives were confirmed by various analytical and spectral 
data. The brief outcomes of the work are given in Table 1.  
The Rf value, melting point (m.p.), IR, 1HNMR, 13CNMR, and 
MS was studied for all the derivatives. The Rf value was observed 
between 0.4 - 0.63 (Table 1) using different solvent system and 
detecting agent. The Rƒ value for different imidazo-thiadiazole 
was found to be higher than the synthesized compounds. The 
melting point of all the compounds are in range between 145-247 
°C (Table 1) and uncorrected. The melting point of all the 
aminothiadiazole was found to be in agreement with the literature.  
The yield of all synthesized derivatives was found in between 35-
48%. The IR spectrum of final derivatives showed absorption at 
1820-1660 cm-1 confirming the carbonyl group. The aromatic 
stretch was shown at 3116.80 cm-1 and the other C-H stretching 
was indicated at 2918.83 cm-1. 
The presence of nitro group was confirmed by the absorption at 
1511.25, 1344.29 cm-1 region.1HNMR spectrum of the final 
derivatives showed singlet of one proton at δ 8.01 confirming the 
presence of CH at 5- position and singlet at δ 2.15 for three 
methyl protons. The mass spectrum showed molecular ion peak at 
m/z 319.2 which is in agreement with the molecular formula 
C17H12N4O2S.  
Table 1: Physical characteristics of synthesized compounds 
Sr. No Compound Molecular 
Formula 
Molecular 
Weight (g) 
Melting point 
(°C) 
Yield (%)       Rf   
1 5a C17H13N3S 291.37 170-173 41 0.62 
2 5b C18H15N3OS 321.40 179-183 45 0.42 
3 5c C17H12N4O2S 336.34 244-247 48 0.48 
4 5d C17H12FN3OS 325.26 217-220 42 0.59 
5 5e C17H12N3S 309.36 231-235 38 0.63 
6 5f C16H9F2N3S 313.20 241-243 42 0.55 
7 6 C18H13N3OS 319.38 174-178 35 0.53 
8 7 C17H12N4O2S 320.07 142-145 40 0.42 
9 8 C17H12BrN3S 370.27 162-165 45 0.54 
Antimicrobial activity 
 
All the synthesized derivatives exhibited very good 
antimicrobial activity (Table 2) when compared to standard 
especially with Gram negative Escherichia coli (MTCC 40). 
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The synthesized compound  6-phenyl-2-p-tolylimidazo[2,1-
b][1,3,4]thiadiazoles-5-carbaldehyde (6) and 6-(4-
methoxyphenyl)-2-p-tolylimidazo[2,1-b][1,3,4]thiadiazoles 
(5b) had moderate antibacterial activity especially with   
Gram negative Escherichia coli (MTCC 40) where 6-phenyl-
2-p-tolylimidazo[2,1-b][1,3,4]thiadiazole (5a) and 2,6-bis(4-
fluorophenyl)imidazo[2,1-b]1,3,4]thiadiazoles (5f) had good 
antibacterial activity. All the compounds were found to be 
inactive against Pseudomonas aeruginosa. All these 
compounds were also tested against fungal strains. In this 
study the  compounds 6-phenyl-2-p-tolylimidazo[2,1-
b][1,3,4]thiadiazoles (5a) and 5-bromo-6-phenyl-2-p-
tolylimidazo[2,1-b][1,3,4]thiadiazole (8) were active against 
F.oxyporium (Table 2).  
Table 2: In vitro antimicrobial activity of synthesized compounds 
 
C. No. 
Zone of inhibition (mm) 
Gram +ve bacteria Gram-ve bacteria Fungal strains 
B. subtilis S. aureus P. aeruginosa E. coli C.albicans F. solani F. oxysporium 
5a 15±2* 13±3* 6±1* 19±2* 17±2* 19±4* 11±1* 
5b 11±1* 11±1* 8±2* 10±3* 21±2* 25±3* 18±3* 
5c NA 9±6* 9±3* 11±3* 20±3* 15±2* 23±1* 
5d NA NA 5±1* 8±2* NA NA NA 
5e NA NA 2±4* NA NA NA NA 
5f 17±2* 12±2* 6±3* 21±1* NA NA NA 
6 13±1* NA 7±2* 17±2* NA NA NA 
7 NA 10±1* 1±3* 9±3* NA NA NA 
8 NA NA 8±1* 6±1* 11±1* 18±3* 21±2* 
St. 23±1* 18±2* 11±1* 28±2* 24±3* 33±2* 29±1* 
St., standard (Ciprofloxacin and Fluconazole) ;  *± SD (n=3) mean of zone of inhibition in mm; NA, No activity. 
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Conclusion 
 
The imidazo[2,1-b][1,3,4] thiadiazole was successfully substituted at 
2, 5 and 6 positions to form various imidazo-thiadiazole 6-phenyl-2-p-
substituted imidazo[2,1-b][1,3,4] thiadiazoles,  6-phenyl-2-p-
tolylimidazo[2,1-b][1,3,4]thiadiazole-5-carbaldehyde,5-Nitroso-6-
phenyl-2-p-tolylimidazo[2,1-b][1,3,4]thiadiazole. All the synthesized 
compounds were characterized using the spectral techniques and 
subjected to antimicrobial activity against various bacterial and fungal 
strains. From the data observed for antimicrobial activity it may be 
concluded that the synthesized derivatives have potential to act as 
antimicrobial agents and activity of the various compounds can be 
increased by substituting these with electron withdrawing groups. The 
synthesized derivatives can be further explored by studying the 
structure activity relationship. 
 
Acknowledgement 
The authors are thankful to SAIF, Panjab University, Chandigarh, for 
providing spectral data of synthesized compounds. We are also 
grateful to IMTECH, Chandigarh for providing help in carrying out 
the antimicrobial screening and Management, ASBASJSM College of 
Pharmacy for providing the necessary facilities. 
Conflict of interest 
The authors declare no conflict of interest. 
 
References 
1. Ansari, K. F.; Lal, C. Synthesis of some new benzimidazole 
derivatives as potential antimicrobial agents.  Eur. J. Med. 
Chem.  2008; 20: 1-6. 
2. Yousif, E.; Rentschler, E.; Salih, N.; Salimon, J.; Hameed, 
A.; Katan, M. Synthesis and antimicrobial screening of tetra 
Schiff bases of 1,2,4,5-tetra (5-amino-1,3,4-thiadiazole-2-yl) 
benzene.  Arabian J. Chem.  (2011), 
doi:10.1016/j.jscs.2011.07.007. 
3. Hu, D. N.; Qui, W. Q.; Wu, B. T.; Fang, L. Z. Genetic 
aspects of antibiotic induces deafness:mitochondrial 
inheritance.  J. Med. Genetics. 1991; 28: 79-83. 
4. Andotra, C. S.; Langer. T. C.; Kotha. A. Synthesis and anti-
inflammatory evalution of methylene bridged benzofuranyl 
imidazo[2,1-b][1,3,4]thiadiazoles. J. Ind. Chem. Sco. 1997; 
74: 125-127. 
5. Khazi, I. A. M.; Mahajanshatti. C. S.; Gadad. A. K.; 
Tranalli. A. D.; Sultanpur. C. M. Synthesis, 
anticonvulsant and analgesic activities of some 6-
substituted imidazo(2,1-b)-1,3,4-thiadiazole-2-
sulfonamides and their 5-bromo derivatives. Arzneim-
Forsch/Drug. Res. 1996; 46: 949-952. 
6. Adreani, A.; Leonia. A.; Locatelli. A.; Morigi. R.; 
Rambaldi. M.; Simon. W. A.; Bilfinger-Senn. J. 
Synthesis and  antisecretatory activity of 6-substituted 
5-cyanomethylimidazo[2,1-b][1,3,4]thiadiazoles. 
Arzneim-Forsch/Drug. Res. 2000; 50: 550-553. 
7. Adreani, A.; Bonazzi. D.; Rambaldi. M.; Fabbri. G.; 
Rainsford. K. D. Synthesis and anti-inflammatory 
evalution of methylene bridged benzofuranyl 
imidazo[2,1-b][1,3,4]thiadiazoles. Eur. J. Med. Chem. 
1982; 17: 271-274. 
8. Adreani, A.; D.; Rambaldi. M.; Mascellani. G.; Bossa. 
R.; Galatulas. I. Synthesis and anti-inflammatory 
evalution of methylene bridged benzofuranyl 
imidazo[2,1-b][1,3,4]thiadiazoles.  Eur. J. Med. Chem. 
1986; 21: 451-453. 
9. Adreani, A.; D.; Rambaldi. M.; Mascellani. Rugarli. P. 
Synthesis and anti-inflammatory evalution of 
methylene bridged benzofuranyl imidazo[2,1-
b][1,3,4]thiadiazoles. Eur. J. Med. Chem. 1987; 22: 19-
22. 
10. Adreani, A.; D.; Rambaldi. M.; Mascellani. A.; 
Locatelli. Adreani. F. Synthesis and anti-inflammatory 
evalution of methylene bridged benzofuranyl 
imidazo[2,1-b][1,3,4]thiadiazoles.  Czech. Chem. 
Commun. 1991; 56: 2436-2447. 
11. Amrey, W. K.; Hoerig, C. H.; Fenichel, R. I.; Chirigos, 
M. A. Synthesis and anti-inflammatory evalution of 
methylene bridged benzofuranyl imidazo[2,1-
b][1,3,4]thiadiazoles.  Immune Modulation Agents and 
Their Mechanism, Marcel Dekker, New York, 1984; 
383-408. 
12. Lamani, R. S.; Shetty,  N. S,; Kamble, R. R,; Khazi, I. 
A. Synthesis and antimicrobial studies of novel 
methylene bridged benzisoxazolyl imidazo[2,1-
b][1,3,4]thiadiazoles. Eur. J. Med. Chem. 2009; 44: 
2828-2833. 
13. Jadhav, V. B,; Kulkarni. M. V.; Rasal, V. P.; Biradar. 
S.; Vinay, M. D. Synthesis and anti-inflammatory 
evalution of methylene bridged benzofuranyl 
imidazo[2,1-b][1,3,4]thiadiazoles.  Eur. J. Med. Chem. 
2008; 43: 1721-1729. 
14. Kumar, R.; Bua, S.; Ram, S.; Capasso, C.; Supuran, 
C.T.; Sharma, P.K.; Benzenesulfonamide bearing 
imidazothiadiazole and thiazolotriazole scaffolds as 
potent tumor associated human carbonic anhydrase IX 
and XII inhibitors. Bioorg. Med. Chem. 2017; 
25(3):1286-1293. 
 
 
 
All © 2017 are reserved by Indian Journal of Pharmaceutical and Biological Research 
 
This Journal is licensed under a Creative Commons Attribution-Non Commercial -Share Alike 3.0 Unported License. This article can be downloaded to 
ANDROID OS based mobile.
 
Cite this article as: Monika Gupta , Baljeet Kaur , Shailender Pratap Singh  and Vivek Kumar Gupta. Synthesis, Spectral 
Studies and Antimicrobial Activity of imidazo[2,1-b][1,3,4]thiadiazole derivatives. Indian J. Pharm. Biol. Res.2017; 5(4):-34-
38. 
